Here Are Wednesday’s Top Wall Street Analyst Research Calls: Abbot Laboratories, AppFolio, Delek US Holdings, Flutter Entertainment, Honeywell Aerospace, Intuitive Surgical, Marvell, NetApp, and More
Wall Street analysts issued upgrades, downgrades, and initiations for several companies. Notable upgrades include Marvell (MRVL) to Buy with a $350 target and NetApp (NTAP) to Outperform with a $300 target. Downgrades include AppFolio (APPF) to Neutral with a $220 target. Initiations include Abbott Laboratories (ABT) with an Overweight rating and $120 target. Major indices closed at record highs, with the S&P 500 at 7,818 and Nasdaq at 27,599.
How this was made
The 30-second read
Why it matters
New coverage and rating changes provide fresh directional cues for the listed stocks.
Market read
Analyst rating changes can move individual stocks and influence sector sentiment.
What to watch
Potential macro headwinds from higher rates could dampen upside.
Background
The article aggregates analyst upgrades, downgrades, and initiations released on Oct 7, 2026.
Ticker impact
Abbott Laboratories was initiated with an Overweight rating and a $120 target price.
likely upside as analysts raise expectations.
Initiation and $120 target represent fresh positive view.
AppFolio was downgraded to Neutral from Buy with a target cut to $220.
potential downside as investors reassess valuation.
Downgrade is new information affecting expectations.
Delek US Holdings was initiated with a Hold rating and an $86 target price.
limited move pending market reaction.
Hold rating provides no strong directional bias.
Flutter Entertainment was upgraded to Buy with a $91 target price.
likely upward pressure.
Buy rating and higher target indicate improved outlook.
Honeywell Aerospace was initiated with a Neutral rating and a $190 target price.
moderate reaction, upside possible if market sees growth.
Neutral rating tempers impact despite high target.
Intuitive Surgical was started with an Overweight rating and a $85 target price.
upward pressure expected.
Overweight rating and target imply confidence in growth.
Marvell was raised to Buy with a $350 target price.
likely upside as investors price in higher expectations.
Buy rating and large target raise indicate strong sentiment.
NetApp was upgraded to Outperform with a $300 target price.
potential modest rally.
Outperform rating is positive but less aggressive than Buy.
Market effects
Broad upgrades in tech and industrials may lift sector sentiment.
U.S. equities likely see modest gains from positive analyst coverage.
Limited; primarily affects U.S.-listed companies.
Counterpoint
Some upgrades may be premature if earnings miss expectations later.
Key entities
- companyAbbott Laboratories
Overweight initiation with $120 target.
- companyAppFolio
Downgraded to Neutral, target $220.
